Paul Silcocks
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Otorhinolaryngology top 10%
Papers in
-
- Oral health in cancer treatment 3
- Oncology 7
- Global Cancer Incidence and Screening 5
- Colorectal Cancer Screening and Detection 2
- Cancer Risks and Factors 2
- Co-authors
- Simon S. Cross (4 shared papers)Dennis W. K. Cotton (3 shared papers)Matthias W. R. Radatz (1 shared paper)Jeremy G. Rowe (1 shared paper)Lee Walton (1 shared paper)Andras Armand Kemeny (1 shared paper)Timothy J. Stephenson (2 shared papers)Janice A. Royds (2 shared papers)
- Journals
- The Journal of Pathology (5 papers)Trials (4 papers)Gynecologic Oncology (2 papers)Twin Research and Human Genetics (2 papers)The Lancet (2 papers)
- Partner nations
- United KingdomAustraliaSweden
In The Last Decade
Paul Silcocks
38 papers receiving 1.4k citations
Paul Silcocks's Hit Papers
Peers
Comparison fields: 5 of 118
- Oncology 394
- Otorhinolaryngology 47
- Pulmonary and Respiratory Medicine 279
- Immunology 155
- Emergency Medicine 62
Countries citing papers authored by Paul Silcocks
This map shows the geographic impact of Paul Silcocks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Silcocks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Silcocks more than expected).
Fields of papers citing papers by Paul Silcocks
This network shows the impact of papers produced by Paul Silcocks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Silcocks. The network helps show where Paul Silcocks may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Silcocks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial Hit paper breakdown → | 2014 | 327 |
| 2 | 2007 | 155 | |
| 3 | 2019 | 99 | |
| 4 | 2019 | 83 | |
| 5 | 1994 | 65 | |
| 6 | 1993 | 60 | |
| 7 | 1991 | 60 | |
| 8 | 1992 | 58 | |
| 9 | 1993 | 44 | |
| 10 | 1994 | 42 | |
| 11 | 2010 | 37 | |
| 12 | 2005 | 29 | |
| 13 | 2016 | 29 | |
| 14 | 1993 | 28 | |
| 15 | 2009 | 26 | |
| 16 | 2006 | 26 | |
| 17 | 1988 | 26 | |
| 18 | 2011 | 26 | |
| 19 | 2005 | 25 | |
| 20 | 1986 | 24 |
About Paul Silcocks
Paul Silcocks is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Statistics and Probability, Pediatrics, Perinatology and Child Health and Cancer Research, having authored 39 papers that have together received 1.5k indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (5 papers), Oral health in cancer treatment (3 papers), Colorectal Cancer Screening and Detection (2 papers), Cancer, Lipids, and Metabolism (2 papers), Bacterial Infections and Vaccines (2 papers), Statistical Methods in Clinical Trials (2 papers), Pneumonia and Respiratory Infections (2 papers) and Cancer Risks and Factors (2 papers). The work is most often cited by research in Oncology (394 citations), Otorhinolaryngology (47 citations), Pulmonary and Respiratory Medicine (279 citations), Immunology (155 citations) and Emergency Medicine (62 citations). Paul Silcocks has collaborated with scholars based in United Kingdom, Australia and Sweden. Frequent co-authors include Simon S. Cross, Dennis W. K. Cotton, Matthias W. R. Radatz, Jeremy G. Rowe, Lee Walton, Andras Armand Kemeny, Timothy J. Stephenson, Janice A. Royds, Jonathan P Bury and Diana Bull. Their work appears in journals such as The Journal of Pathology, Trials, Gynecologic Oncology, Twin Research and Human Genetics and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.